Medriva

A total of 1,97,244 confirmed COVID-19 cases were recorded in Syria between March 22, 2020, and April 23, 2022, including 102 878 (52.16 percent) from north-west Syria (NWS), 55 795 (28.29 percent) from government-controlled regions (GoS), and 38 571 (19.55 percent) from north-east Syria (NES). 7 182 deaths were reported during the same time period, with 3 150 (43.86 percent) coming from GoS, 2 459 (34.24 percent) from NWS, and 1 573 (21.90 percent) from NES. The Case Fatality Rate(CFR) is 3.6 percent overall.

GoS had the greatest CFR (5.6%), followed by NES (4.1%), and NWS (4.0%). (2.4 percent ). The high CFR rates in GoS can be attributed to the testing policy of only treating the most critical and severe cases. The number of confirmed COVID-19 cases reported in Syria reduced by 94% (n=371) when compared to the previous month (n=6,677). NWS (n=260) has decreased by 70% as compared to March (n=5,397). From March (n=1,120), the number of cases recorded in GoS has reduced by 99.1% (n=100). Furthermore, NES reported a 93% drop in new cases, with 11 new cases compared to 160 the prior month.

(WHO Syria COVID-19 key performance indicators – January 2022)

New COVID-19 instances have been reported in all Syrian governorates. For the month of April, the number of COVID-19 reported cases and their percentage of the national total were as follows in all 14 governorates of Syria: Aleppo 38.81 percent (n=144), Idleb 35.04 percent (n=130), Hama 6.47 percent (n=24), Tartous 4.58 percent (n=17), Damascus 4.04 percent (n=15), Homs 2.7 percent (n=eight), Al-Hasakeh 2.16 percent (n=eight), As-Sweida 1.89 percent (n=seven), Dar’a 1.62 percent (n=6)

Since the outbreak in Syria began, four waves of COVID-19 have been found; the first wave peaked in November 2020, and the second wave peaked in April 2021, with the Alfa and Beta variants being the most frequent. The Delta variant was validated in the third wave, which ended in September 2021. The fourth wave, which begins in February 2022, corresponds to the confirmation of the Omicron variety in Syria’s northwest.

Leave a Reply

Your email address will not be published.